22/05/2020
Kelun Pharmaceutical (002422) 2018 Annual Report Review: New Product Volume Helps Maintain Faster Growth in Income
[Key points of investment]Kelun Ph
21/05/2020
Supor (002032) 2019 Interim Report Comments: Performance Meets Expected Repurchase Incentive Plan, Establish Long-Term Mechanism
Investment points: I
20/05/2020
Meike Home (600337) 2019 First Quarterly Report Review: The rebound in first- and second-tier real estate helps to improve quarterly performance
Inve
18/05/2020
Feike Electric (603868) 2019 Interim Report Review: Double Pressure on Revenue and Profit Expect Channel Adjustments to Bring Operational Improvements
17/05/2020
Oupai Home (603833): Performance Forecast Meets Expected Key Product Categories
Investment Highlights Event: The company released a 2019 performan
16/05/2020
Lingrui Pharmaceutical (600285) annual report comments: performance is slightly lower than expected marketing integration continues to advance
Event:
15/05/2020
Xingang shares (600782): Annual report performance is dazzling and profit hits record high
Event: The company released its 2018 annual report: in
14/05/2020
Shanxi Fenjiu (600809): Significant implementation of strategy
Introduction to this report: Performance is in line with expectations.
Both ends
13/05/2020
Energy war "epidemic": "two barrels of oil" opened full-power masks
For stocks, please read Jin Qilin analyst research report, authoritative, profess